Phase 4
N=34
Effect of Coconut Water on Hydration Status in Pediatric Population
Sports Nutrition
Bottom Line
View on ClinicalTrials.gov: NCT05562401 ↗Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: To Determine the Effect of AC vs EO on Hydration Status in Adolescents Who Perform Physical Exercise of Aerobic Competition. — 53; 36; 15; 32 Number participants euhydrated
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Coconut Water (Device); Oral Electrolytes (Drug)
- Age
- Pediatric · 12+ yrs
- Sex
- Male
- Sponsor
- Universidad de Colima
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY To Determine the Effect of AC vs EO on Hydration Status in Adolescents Who Perform Physical Exercise of Aerobic Competition. |
53; 36; 15; 32 | — |
| SECONDARY Number of Participants With Dehydration Event After Exercise and Assigned Treatment Evaluated by Water Loss Related to Body Mass. |
— | — |
| SECONDARY Number of Participants With a Dehydration Event After Exercise and the Assigned Treatment Evaluated by the Percentage of Water Lost by Bioelectrical Impedance. |
— | — |
| SECONDARY Number of Participants With Post-exercise Dehydration Event and Assigned Treatment Assessed by Urine Specific Gravity in g/Cubic cm. |
— | — |
| SECONDARY Number of Participants With Post-exercise Dehydration Event in Both Assigned Treatments Assessed by Body Mass, Bioelectrical Impedance, and Urine Specific Gravity Using Chi-square or T-test. |
— | — |
Summary
Introduction: The dehydration is a very common problem that is often not identified. The pediatric population is more susceptible to dehydration due to its physiological characteristics. Proper hydration is crucial for health since any degree of dehydration causes a reduction in physical and mental work capacity, hence the importance of preventing it by considering the type of drink. There are multiple beverage options, including industrial oral electrolytes (OE), on the other hand, coconut water (CW) has been studied as a natural alternative beverage with characteristics that can help maintain a state of euhydration. Objective: To determine if AC has a greater effect on hydration status than OE in adolescents who perform physical exercise. Material and methods: RCT, double blind. 34 subjects aged 13.02 ± 1.08 years were selected, assigned to treatment with either OE (Electrolit®) or CW. They received a weekly physical exercise session (4 weeks). Hydration was personalized (ml x kilograms of weight) and hydration was evaluated by Urine Specific Gravity (USG), Total Body Water (TBW) by bioimpedance and changes in body mass. Results:
Sesion 1 CW: Euhydrated (12) Dehydrated (5); OE: Euhydrated (8) Dehydrated (9); p value=0,16
Sesion 2 CW: Euhydrated (12) Dehydrated (5); OE: Euhydrated (7) Dehydrated (10); p value=0,08
Sesion 3 CW: Euhydrated (13) Dehydrated (4); OE: Euhydrated (13) Dehydrated (4); p value=1,00
Sesion 4 CW: Euhydrated (16) Dehydrated (1); OE: Euhydrated (8) Dehydrated (9); p value=0,007*
Conclusion: AC and OE have the same effect on hydration levels in adolescents who perform physical exercise.
Eligibility Criteria
Inclusion Criteria
- Students that belong to "Instituto Salesiano Fray Pedro de Gante".
- Those students who are 12 years old and under 18 years of age.
- The parent or guardian of the adolescent and the student himself must agree to participate and comply with the autographed authorization of the informed consent letter.
- The adolescent must be in good physical and mental health.
Exclusion Criteria
- Adolescents who suffer from a chronic disease such as obesity, hypertension, DM, asthma, COPD, cancer, injuries or physical disabilities.
- That the adolescent is allergic to any component of the treatments.
Elimination criteria:
- Adolescents who do not complete physical training sessions.
- That the adolescent presents a serious sports injury (fracture or sprain) during any of the physical exercise sessions.
- That the adolescent decides to withdraw once the practical research stage has begun.
Data sourced from ClinicalTrials.gov (NCT05562401). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.